NCT04488393View on ClinicalTrials.gov

Clinical Performance of NIPT in Multiple Gestation Pregnancies

CompletedOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

November 15, 2021

Study Completion Date

June 19, 2022

Conditions

Trisomy 21 in Fetus

Interventions

DEVICE

MaterniT21 PLUS and GENOME Laboratory-Developed Tests

Both the MaterniT21 PLUS and GENOME are intended for use as laboratory developed test that analyze ccfDNA extracted from a maternal blood sample utilizing Massively Parallel Sequencing (MPS) technology.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors

collaborator

Sequenom, Inc/Laboratory Corporation of America Holdings

UNKNOWN

lead

University of Pennsylvania

OTHER

NCT04488393 - Clinical Performance of NIPT in Multiple Gestation Pregnancies | Biotech Hunter | Biotech Hunter